Lumakras User Reviews & Ratings
Lumakras has an average rating of 10.0 out of 10 from a total of 1 reviews on Drugs.com. 100% of reviewers reported a positive experience, while 0% reported a negative experience.
| Condition | Avg. Rating | Reviews | Compare |
|---|---|---|---|
| Non-Small Cell Lung Cancer | 1 reviews for Non-Small Cell Lung Cancer | 57 medications | |
| Add your review | |||
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
More about Lumakras (sotorasib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
For Non-Small Cell Lung Cancer "I am very fortunate as I have only been taking Lumakras for 12 weeks and have shown positive results already. In my 1st CT scan since starting the drug, my cancer cells have remained the same, some have shrunk in size, and some have disappeared. My prescription is to take 3 pills of 320mg each in the morning."